Phase 4
Completed N=101
Skin and Soft Tissue Infection (SSTI) Study
Skin Diseases, Infectious · Soft Tissue Infections
Source: ClinicalTrials.gov NCT02600871 ↗
Enrolled (actual)
101
Serious AEs
0.0%
Results posted
Mar 2018
Primary outcomePrimary: Number of Participants With a Clinical Cure — 45; 42 Participants — p=0.71
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to determine if the use Provodine as an antiseptic and hand wash once daily for at least 7 days will have better healing, better health outcomes, fewer treatment failures and fewer infections themselves and among their household contacts than those who do not use Provodine.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With a Clinical Cure |
45; 42 | 0.71 |
| SECONDARY Infection Rates of Household Contacts |
2; 4 | — |
| SECONDARY Rate of New Lesion Development |
8; 8 | — |
Eligibility Criteria
Inclusion Criteria
- Skin abscess
- Treatment requiring incision and drainage
Exclusion Criteria
- Unable or unwilling to provide informed consent
- Homeless, incarcerated, or living in a group home
- Abscess on the face or breast
- Abscess requiring surgical drainage in the operating room or requiring admission to the hospital
- Intravenous drug users
- Previous enrollment in this study
- Documented history of iodine sensitivity
Data sourced from ClinicalTrials.gov (NCT02600871). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.